Related Experiment Video
Updated: Jul 6, 2026
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Functional identification of genes causing estrogen independence of human breast cancer cells
Ton van Agthoven1, Jos Veldscholte, Marcel Smid
1Department of Pathology, Josephine Nefkens Institute, Be 432, Erasmus MC-University Medical Center Rotterdam, P.O. Box 2040, Rotterdam, CA, 3000, The Netherlands.
Abstract:
Endocrine treatment of breast cancer is widely applied and effective. However, in advanced disease cases, the tumors will eventually progress into an estrogen-independent and therapy-resistant phenotype. To elucidate the molecular mechanisms underlying this endocrine therapy failure, we applied retroviral insertion mutagenesis to identify the main genes conferring estrogen independence to human breast cancer cells. Estrogen-dependent ZR-75-1 cells were infected with replication-defective retroviruses followed by selection with the anti-estrogen 4-hydroxy-tamoxifen. In the resulting panel of 79 tamoxifen-resistant cell lines, the viral integrations were mapped within the human genome. Genes located in the immediate proximity of the retroviral integration sites were characterized for altered expression and their capacity to confer anti-estrogen resistance when transfected into breast cancer cells. Out of 15 candidate BCAR (breast cancer anti-estrogen resistance) genes, seven (AKT1, AKT2, BCAR1, BCAR3, EGFR, GRB7, and TRERF1/BCAR2) were shown to directly underlie estrogen independence. Our results show that insertion mutagenesis is a powerful tool to identify BCAR loci, which may provide insights into the molecular and cellular mechanisms of breast tumor progression and therapy resistance thereby offering novel targets for the development of tailor-made therapeutical and prevention strategies.
Insights
Researchers identified key genes driving estrogen independence in breast cancer, a major cause of endocrine therapy failure. This discovery offers new targets for developing personalized breast cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Endocrine therapy is a cornerstone treatment for breast cancer.
- Tumor progression in advanced breast cancer often leads to estrogen independence and resistance to therapy.
- Understanding the molecular mechanisms of endocrine therapy failure is crucial for improving patient outcomes.
Purpose of the Study:
- To identify genes responsible for estrogen independence in breast cancer cells, leading to endocrine therapy resistance.
- To elucidate the molecular mechanisms underlying tamoxifen resistance in breast cancer.
Main Methods:
- Utilized retroviral insertion mutagenesis to infect estrogen-dependent breast cancer cells (ZR-75-1).
- Selected for tamoxifen resistance to generate 79 resistant cell lines.
- Mapped viral integration sites and identified candidate genes (BCAR genes) associated with resistance.
Main Results:
- Identified 15 candidate breast cancer anti-estrogen resistance (BCAR) genes.
- Confirmed seven genes (AKT1, AKT2, BCAR1, BCAR3, EGFR, GRB7, TRERF1/BCAR2) directly confer estrogen independence.
- Demonstrated that retroviral insertion mutagenesis is effective for identifying BCAR loci.
Conclusions:
- Insertion mutagenesis is a powerful tool for discovering genes involved in breast cancer endocrine therapy resistance.
- The identified BCAR genes provide insights into tumor progression and resistance mechanisms.
- These findings offer potential novel targets for developing targeted therapies and prevention strategies for breast cancer.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...